Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > The full article published yesterday

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon Feb 26, 2024 11:59am

64 Views

Post# 35899260

RE:RE:RE:RE:RE:RE:RE:RE:RE:The full article published yesterday

So what's the next milestone now. There is value creation scheduled for the second half of the year according to our CEO. Obviously after the AGM to secure another mandate. Then they can derisk again with another raise I suppose. Until then they already prepared for some yoyo numbers and what am I leaving out. I don't know, does anyone have clues. New board members maybe.

<< Previous

Bullboard Posts

Next >>

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle